Youmanitarian 11 Jun 2021

Volgende

Automatisch afspelen

Understand Cancer & Reduce Cancer Risk | Dr. Peter Attia & Dr. Andrew Huberman

uchetex · 13 Bekeken

Defining Progression in Metastatic Kidney Cancer

0

0

10 Bekeken

TAKE ACTION

Donations would go to support charities for How-To & Style

In How-To & Style

Panelists Robert A. Figlin, MD; Michael R. Harrison, MD; David I. Quinn, MBBS, PhD; and Eric Jonasch, MD, discuss defining clinical progression and optimizing use of VEGF TKI therapy to achieve the highest dose intensity before switching in patients with metastatic kidney cancer.

Laat meer zien

More ways to take action

Explore ways that you can help bring a solution to this issue.

Create Youms with
hashtags How-To & Style

Create a challenge to
bring awareness to this issue for people to complete

Create a fundraiser to
support a charity that tackle this issue

Volunteer at charitable organization
that support this cause

Create a movement page dedicated to this cause to bring awareness.

Start a uCharity for this cause and invite people to join it to support this cause

Volgende

Automatisch afspelen

Understand Cancer & Reduce Cancer Risk | Dr. Peter Attia & Dr. Andrew Huberman

uchetex · 13 Bekeken

Huis

Categorieën